Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of “Hold” from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been given a consensus recommendation of “Hold” by the fourteen research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $86.8333.

Several equities research analysts have recently commented on HSIC shares. JPMorgan Chase & Co. boosted their price objective on Henry Schein from $78.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Citigroup started coverage on Henry Schein in a report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price objective for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Henry Schein in a report on Monday, May 4th. Robert W. Baird set a $97.00 target price on Henry Schein in a research report on Wednesday, May 6th. Finally, BTIG Research started coverage on Henry Schein in a research report on Thursday, April 16th. They set a “neutral” rating on the stock.

Henry Schein Stock Performance

Shares of HSIC stock opened at $74.21 on Tuesday. The company has a market cap of $8.45 billion, a P/E ratio of 22.42, a PEG ratio of 1.86 and a beta of 0.82. The stock has a 50 day simple moving average of $74.33 and a two-hundred day simple moving average of $75.71. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36. Henry Schein has a fifty-two week low of $61.94 and a fifty-two week high of $89.29.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The business had revenue of $3.37 billion during the quarter, compared to the consensus estimate of $3.34 billion. During the same period in the previous year, the company posted $1.15 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Research analysts forecast that Henry Schein will post 5.31 earnings per share for the current year.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,844 shares of Henry Schein stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $80.36, for a total transaction of $228,543.84. Following the transaction, the director owned 21,961 shares of the company’s stock, valued at $1,764,785.96. The trade was a 11.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William K. Daniel bought 10,000 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the transaction, the director owned 20,000 shares of the company’s stock, valued at $1,383,800. The trade was a 100.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold 105,911 shares of company stock valued at $8,574,982 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. CYBER HORNET ETFs LLC purchased a new position in Henry Schein in the second quarter worth $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein in the second quarter worth $27,000. Flagship Harbor Advisors LLC purchased a new position in Henry Schein in the fourth quarter worth $30,000. Federated Hermes Inc. purchased a new position in Henry Schein in the fourth quarter worth $32,000. Finally, Los Angeles Capital Management LLC purchased a new position in Henry Schein in the fourth quarter worth $37,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.